Found: 15
Select item for more details and to access through your institution.
First-line treatment of metastatic melanoma: role of nivolumab.
- Published in:
- ImmunoTargets & Therapy, 2017, v. 6, p. 1, doi. 10.2147/ITT.S110479
- By:
- Publication type:
- Article
Discovery of oncogenic ROS1 missense mutations with sensitivity to tyrosine kinase inhibitors.
- Published in:
- EMBO Molecular Medicine, 2023, v. 15, n. 10, p. 1, doi. 10.15252/emmm.202217367
- By:
- Publication type:
- Article
ASO Visual Abstract: Neoadjuvant Chemotherapy and Endocrine Therapy for Older Patients with Estrogen Receptor Positive Breast Cancer—Comparison of Approaches.
- Published in:
- 2023
- By:
- Publication type:
- Abstract
Neoadjuvant Chemotherapy and Endocrine Therapy for Older Patients with Estrogen Receptor Positive Breast Cancer: Comparison of Approaches.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2023, v. 30, n. 10, p. 6141, doi. 10.1245/s10434-023-13880-y
- By:
- Publication type:
- Article
Treatment Patterns and Outcomes of Women with Breast Cancer and Supraclavicular Nodal Metastases.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2021, v. 28, n. 4, p. 2146, doi. 10.1245/s10434-020-09024-1
- By:
- Publication type:
- Article
Surgery for Men with Breast Cancer: Do the Same Data Still Apply?
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2020, v. 27, n. 12, p. 4720, doi. 10.1245/s10434-020-08901-z
- By:
- Publication type:
- Article
Evaluation of alpelisib-induced hyperglycemia prophylaxis and associated risk factors in PIK3CA-mutated hormone-receptor positive, human epidermal growth factor-2 negative advanced breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 197, n. 2, p. 369, doi. 10.1007/s10549-022-06798-8
- By:
- Publication type:
- Article
Extent of axillary surgery in inflammatory breast cancer: a survival analysis of 3500 patients.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 180, n. 1, p. 207, doi. 10.1007/s10549-020-05529-1
- By:
- Publication type:
- Article
Metaplastic Breast Cancer Treatment and Outcomes in 2500 Patients: A Retrospective Analysis of a National Oncology Database.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2018, v. 25, n. 8, p. 2249, doi. 10.1245/s10434-018-6533-3
- By:
- Publication type:
- Article
Biomarkers of Immune Checkpoint Blockade Response in Triple-Negative Breast Cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Checkpoint Blockade Strategies in the Treatment of Breast Cancer: Where We Are and Where We Are Heading.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Cost-Effectiveness Analysis of the Oncotype DX Breast Recurrence Score<sup>®</sup> Test from a US Societal Perspective.
- Published in:
- ClinicoEconomics & Outcomes Research, 2024, v. 16, p. 471, doi. 10.2147/CEOR.S449711
- By:
- Publication type:
- Article
A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013.
- Published in:
- NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00500-3
- By:
- Publication type:
- Article
Early Stage HER2-Positive Breast Cancers Not Achieving a pCR From Neoadjuvant Trastuzumab- or Pertuzumab-Based Regimens Have an Immunosuppressive Phenotype.
- Published in:
- 2018
- By:
- Publication type:
- journal article
TBCRC 039: a phase II study of preoperative ruxolitinib with or without paclitaxel for triple-negative inflammatory breast cancer.
- Published in:
- Breast Cancer Research, 2024, v. 26, p. 1, doi. 10.1186/s13058-024-01774-0
- By:
- Publication type:
- Article